济民健康: 济民健康管理股份有限公司股票交易风险提示公告

Core Viewpoint - The company has experienced significant stock price fluctuations, with a cumulative increase of 53.78% from August 13 to August 19, 2025, and a subsequent trading halt on August 20, indicating potential market overreaction and speculative trading risks [1] Group 1: Trading Risks - The company's stock price saw a cumulative increase of 53.78% from August 13 to August 19, 2025, with two instances of trading anomalies [1] - On August 20, 2025, the stock hit the daily limit, with a turnover rate of 31.31%, both metrics significantly exceeding industry averages [1] - The company emphasizes that its fundamental business conditions have not changed, suggesting that the stock price increase may be driven by market sentiment and irrational speculation, leading to considerable trading risks [1] Group 2: Operating Performance Risks - The company anticipates a net loss attributable to shareholders ranging from -55 million to -46 million yuan, indicating a decline in performance compared to the same period last year [2] Group 3: Other Risk Notifications - The company advises investors to refer to its designated information disclosure media for accurate updates and to exercise caution in their investment decisions [3]